verapamil has been researched along with dihydroergotoxine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rao, GH; Reddy, KR; White, JG | 1 |
| Addonizio, VP; Barnathan, ES; Shattil, SJ | 1 |
| Rietbrock, N; Woodcock, BG | 1 |
| Amenta, F; Bronzetti, E; Felici, L; Polidori, C | 1 |
4 other study(ies) available for verapamil and dihydroergotoxine
| Article | Year |
|---|---|
Modification of human platelet response to sodium arachidonate by membrane modulation.
Topics: Adult; Arachidonic Acids; Blood Platelets; Cell Membrane; Cyclic AMP; Dihydroergotoxine; Dose-Response Relationship, Drug; Epinephrine; Epoprostenol; Humans; Platelet Aggregation; Thromboxane B2; Verapamil | 1981 |
Interaction of verapamil with human platelet alpha-adrenergic receptors.
Topics: Binding, Competitive; Blood Platelets; Clonidine; Dihydroergotoxine; Epinephrine; Humans; Kinetics; Platelet Aggregation; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Verapamil; Yohimbine | 1982 |
[Drugs with first-pass elimination. Verapamil and dihydroergotamine alkaloids].
Topics: Animals; Biological Availability; Dihydroergotoxine; Ergot Alkaloids; Humans; Kinetics; Liver; Liver Circulation; Liver Diseases; Metabolic Clearance Rate; Rats; Verapamil | 1982 |
Interactions between calcium channel blockers and alpha-adrenoceptors in the human coronary and mammary arteries: a radioligand binding study.
Topics: Adolescent; Adult; Binding, Competitive; Calcium Channel Blockers; Coronary Vessels; Dihydroergotoxine; Female; Guanosine Triphosphate; Humans; In Vitro Techniques; Male; Mammary Arteries; Radioligand Assay; Receptors, Adrenergic, alpha; Verapamil | 1994 |